147 related articles for article (PubMed ID: 9574533)
1. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures.
Shi Y; Smith KD; Lutz CT
J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533
[TBL] [Abstract][Full Text] [Related]
2. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
Smith KD; Lutz CT
J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
[TBL] [Abstract][Full Text] [Related]
3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.
Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT
Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
6. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
[TBL] [Abstract][Full Text] [Related]
7. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.
Smith KD; Epperson DF; Lutz CT
Immunogenetics; 1996; 43(1-2):27-37. PubMed ID: 8537119
[TBL] [Abstract][Full Text] [Related]
8. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
[TBL] [Abstract][Full Text] [Related]
9. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
Chen BP; Madrigal A; Parham P
J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
[TBL] [Abstract][Full Text] [Related]
11. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
[TBL] [Abstract][Full Text] [Related]
13. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).
de la Salle H; Saulquin X; Mansour I; Klayme S; Fricker D; Zimmer J; Cazenave JP; Hanau D; Bonneville M; Houssaint E; Lefranc G; Naman R
Clin Exp Immunol; 2002 Jun; 128(3):525-31. PubMed ID: 12067308
[TBL] [Abstract][Full Text] [Related]
15. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
Wang F; Li X; Annis B; Faustman DL
Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle LH; Goodall JC; Gaston JS
Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells.
Russ G; Ramachandra M; Hrycyna CA; Gottesman MM; Pastan I; Bennink JR; Yewdell JW
Cancer Res; 1998 Oct; 58(20):4688-93. PubMed ID: 9788623
[TBL] [Abstract][Full Text] [Related]
18. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
19. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
[TBL] [Abstract][Full Text] [Related]
20. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
